Table 3. Main indications for antithrombotic agents’ use, n (%).

	Phase One N = 125	Phase Two N = 110	P-value*
Vascular access patency	10 (13.5)	13 (18.6)	0.41
Coronary artery disease	20 (23.8)	30 (34.5)	0.12
Stroke	0 (0.0)	1 (1.7)	0.29
Peripheral artery disease	14 (17.9)	5 (8.1)	0.09
Primary prevention	13 (16.9)	0 (0.0)	0.001
Atrial fibrillation	4 (5.9)	3 (5.0)	1.00
Deep venous thrombosis	0 (0.0)	1 (1.7)	0.29

*Chi-square test, significant p-value < 0.05.